Immunoreactive glycoprotein GP19 of ehrlichia canis
Abstract:
The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
Public/Granted literature
Information query
Patent Agency Ranking
0/0